MedAdvisor Future Growth
Future criteria checks 4/6
MedAdvisor is forecast to grow earnings and revenue by 69.1% and 13.4% per annum respectively. EPS is expected to grow by 69.2% per annum. Return on equity is forecast to be 18.1% in 3 years.
Key information
69.1%
Earnings growth rate
69.2%
EPS growth rate
| Healthcare Services earnings growth | 20.8% |
| Revenue growth rate | 13.4% |
| Future return on equity | 18.1% |
| Analyst coverage | Low |
| Last updated | 01 Nov 2024 |
Recent future growth updates
Recent updates
Earnings and Revenue Growth Forecasts
| Date | Revenue | Earnings | Free Cash Flow | Cash from Op | Avg. No. Analysts |
|---|---|---|---|---|---|
| 6/30/2027 | 184 | 13 | 16 | 21 | 2 |
| 6/30/2026 | 162 | 9 | 14 | 16 | 3 |
| 6/30/2025 | 142 | 2 | 5 | 9 | 3 |
| 6/30/2024 | 122 | 1 | 3 | 5 | N/A |
| 3/31/2024 | 116 | -4 | -2 | 0 | N/A |
| 12/31/2023 | 109 | -9 | -7 | -6 | N/A |
| 9/30/2023 | 104 | -10 | -4 | -4 | N/A |
| 6/30/2023 | 98 | -11 | -2 | -1 | N/A |
| 3/31/2023 | 96 | -8 | 7 | 7 | N/A |
| 12/31/2022 | 93 | -5 | 16 | 16 | N/A |
| 9/30/2022 | 80 | -11 | 8 | 8 | N/A |
| 6/30/2022 | 68 | -17 | -1 | 0 | N/A |
| 3/31/2022 | 66 | -16 | -6 | -5 | N/A |
| 12/31/2021 | 64 | -14 | -11 | -11 | N/A |
| 9/30/2021 | 52 | -14 | -12 | -12 | N/A |
| 6/30/2021 | 39 | -14 | -13 | -13 | N/A |
| 3/31/2021 | 28 | -13 | -10 | -9 | N/A |
| 12/31/2020 | 18 | -12 | -6 | -6 | N/A |
| 9/30/2020 | 14 | -11 | -8 | -7 | N/A |
| 6/30/2020 | 10 | -10 | -9 | -9 | N/A |
| 3/31/2020 | 9 | -9 | -9 | -8 | N/A |
| 12/31/2019 | 9 | -9 | -8 | -8 | N/A |
| 9/30/2019 | 9 | -8 | -8 | -7 | N/A |
| 6/30/2019 | 8 | -8 | -7 | -7 | N/A |
| 3/31/2019 | 8 | -7 | -6 | -6 | N/A |
| 12/31/2018 | 7 | -7 | -6 | -5 | N/A |
| 9/30/2018 | 7 | -6 | -5 | -4 | N/A |
| 6/30/2018 | 7 | -4 | -4 | -3 | N/A |
| 3/31/2018 | 6 | -4 | N/A | -3 | N/A |
| 12/31/2017 | 6 | -4 | N/A | -3 | N/A |
| 9/30/2017 | 5 | -4 | N/A | -3 | N/A |
| 6/30/2017 | 4 | -3 | N/A | -2 | N/A |
| 3/31/2017 | 3 | -4 | N/A | -3 | N/A |
| 12/31/2016 | 2 | -4 | N/A | -3 | N/A |
| 9/30/2016 | 2 | -4 | N/A | -3 | N/A |
| 6/30/2016 | 1 | -3 | N/A | -3 | N/A |
| 3/31/2016 | 1 | -2 | N/A | -2 | N/A |
| 12/31/2015 | 2 | -1 | N/A | -1 | N/A |
| 9/30/2015 | 2 | -1 | N/A | -1 | N/A |
| 6/30/2015 | 2 | -1 | N/A | 0 | N/A |
| 6/30/2014 | 1 | -1 | N/A | -1 | N/A |
Analyst Future Growth Forecasts
Earnings vs Savings Rate: MDR's forecast earnings growth (69.1% per year) is above the savings rate (2.6%).
Earnings vs Market: MDR's earnings (69.1% per year) are forecast to grow faster than the Australian market (12.5% per year).
High Growth Earnings: MDR's earnings are expected to grow significantly over the next 3 years.
Revenue vs Market: MDR's revenue (13.4% per year) is forecast to grow faster than the Australian market (5.7% per year).
High Growth Revenue: MDR's revenue (13.4% per year) is forecast to grow slower than 20% per year.
Earnings per Share Growth Forecasts
Future Return on Equity
Future ROE: MDR's Return on Equity is forecast to be low in 3 years time (18.1%).